HURA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
8.8M
+16.4%
7.5M
-7.9%
8.2M
+21.5%
6.7M
-31.9%
9.9M
R&D
6.6M
+26.5%
5.2M
-13.6%
6.1M
+21.9%
5.0M
+0.8%
4.9M
SG&A
2.1M
-6.7%
2.3M
+247.1%
-1561727
-188.7%
1.8M
-5.4%
1.9M
Operating Income
-8763284
-16.4%
-7529899
+7.9%
-8173357
-21.5%
-6729603
+31.9%
-9875956
EBITDA
-8735180
-16.4%
-7506427
-67.9%
-4471195
+33.3%
-6708311
+1.0%
-6775603
Net Income
-9223298
-22.4%
-7536598
-11.5%
-6761316
+4.8%
-7102455
+25.4%
-9523835
EPS (Basic)
$-0.14
-7.7%
$-0.13
+0.0%
$-0.13
+7.1%
$-0.14
+33.3%
$-0.21
EPS (Diluted)
$-0.14
-7.7%
$-0.13
+0.0%
$-0.13
+7.1%
$-0.14
+33.3%
$-0.21
Shares (Diluted)
64.0M
+6.6%
60.0M
+13.1%
53.1M
+4.8%
50.7M
+13.7%
44.6M
TuHURA Biosciences (HURA) โ€” Financials